This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lockhart, S. R.
Right arrow Articles by Diekema, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lockhart, S. R.
Right arrow Articles by Diekema, D. J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2009, p. 1216-1217, Vol. 47, No. 4
0095-1137/09/$08.00+0     doi:10.1128/JCM.02315-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Identification of Candida nivariensis and Candida bracarensis in a Large Global Collection of Candida glabrata Isolates: Comparison to the Literature{triangledown}

Shawn R. Lockhart,1* Shawn A. Messer,1 Michael Gherna,2 Justin A. Bishop,2 William G. Merz,2 Michael A. Pfaller,1 and Daniel J. Diekema1

University of Iowa, Carver College of Medicine, Iowa City, Iowa 52242,1 Johns Hopkins Medical Institute, Baltimore, Maryland2

Received 2 December 2008/ Returned for modification 20 January 2009/ Accepted 21 January 2009

We analyzed 1,598 Candida glabrata isolates for the presence of the cryptic species Candida nivariensis and Candida bracarensis. Both species were very rare in this collection (0.2% prevalence), despite the number of isolates analyzed and the global distribution of the isolates. We saw no associated antifungal resistance in C. nivariensis.


* Corresponding author. Present address: Centers for Disease Control and Prevention, 1600 Clifton Rd., Mailstop G-11, Atlanta, GA 30333. Phone: (404) 639-2569. Fax: (404) 639-3546. E-mail: gyi2{at}cdc.gov

{triangledown} Published ahead of print on 4 February 2009.


Journal of Clinical Microbiology, April 2009, p. 1216-1217, Vol. 47, No. 4
0095-1137/09/$08.00+0     doi:10.1128/JCM.02315-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Diekema, D. J., Messer, S. A., Boyken, L. B., Hollis, R. J., Kroeger, J., Tendolkar, S., Pfaller, M. A. (2009). In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of Rare Candida Species as Determined by CLSI Broth Microdilution Methods. J. Clin. Microbiol. 47: 3170-3177 [Abstract] [Full Text]  
  • Marklein, G., Josten, M., Klanke, U., Muller, E., Horre, R., Maier, T., Wenzel, T., Kostrzewa, M., Bierbaum, G., Hoerauf, A., Sahl, H.-G. (2009). Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Fast and Reliable Identification of Clinical Yeast Isolates. J. Clin. Microbiol. 47: 2912-2917 [Abstract] [Full Text]